Literature DB >> 20097631

Genistein and daidzein act on a panel of genes implicated in cell cycle and angiogenesis by polymerase chain reaction arrays in human prostate cancer cell lines.

Nadège Rabiau1, Myriam Kossaï, Martin Braud, Nasséra Chalabi, Samir Satih, Yves-Jean Bignon, Dominique J Bernard-Gallon.   

Abstract

BACKGROUND: The prostate cancer most frequently affects men. The ethnic origin and family antecedents of prostate cancer are established as risk factors. The genetic factors associated with environmental factors such as the nutrition also play a role in the development of the cancer. Epidemiological studies showed that the Asian populations exhibited an incidence of prostate cancer markedly subordinate by comparison with the Western populations. This would be explained partially by their important consumption of soy. Both main phytoestrogens of soy, the genistein and the daidzein, present anti-proliferative properties.
METHODS: For that purpose, we used different prostate cancer cell lines (LNCaP, DU 145, PC-3) and, by flow cytometry, we determined the concentration of phytoestrogens inducing a cell cycle arrest and the required time of incubation.
RESULTS: Then, the effects of 40microM genistein or 110microM daidzein for 48h were determined and studied on the expression of genes involved in the human cell cycle and angiogenesis and conducted by SYBR green quantitative PCR.
CONCLUSION: We demonstrated modulations of cyclin-dependent kinase-related pathway genes, DNA damage-signaling pathway and a down-regulation of EGF and IGF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097631     DOI: 10.1016/j.canep.2009.12.018

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  13 in total

1.  MRE11A and SKP2 genes are associated with the increased cytotoxicity induced by the synergistic effects of cisplatin and gemcitabine in bladder cancer cells.

Authors:  Glenda Nicioli da Silva; Elaine Aparecida de Camargo; André Luiz Ventura Sávio; Daisy Maria Fávero Salvadori
Journal:  Mol Biol Rep       Date:  2014-03-21       Impact factor: 2.316

Review 2.  Soy intake and chronic disease risk: findings from prospective cohort studies in Japan.

Authors:  Chisato Nagata
Journal:  Eur J Clin Nutr       Date:  2020-09-11       Impact factor: 4.016

Review 3.  Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME.

Authors:  Zhen Yang; Kaustubh Kulkarni; Wei Zhu; Ming Hu
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

Review 4.  Soy isoflavones and prostate cancer: a review of molecular mechanisms.

Authors:  Abeer M Mahmoud; Wancai Yang; Maarten C Bosland
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-25       Impact factor: 4.292

5.  Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.

Authors:  Michelle M Martínez-Montemayor; Elisa Otero-Franqui; Joel Martinez; Alina De La Mota-Peynado; Luis A Cubano; Suranganie Dharmawardhane
Journal:  Clin Exp Metastasis       Date:  2010-06-02       Impact factor: 5.150

Review 6.  Soy and breast cancer: focus on angiogenesis.

Authors:  Lenka Varinska; Peter Gal; Gabriela Mojzisova; Ladislav Mirossay; Jan Mojzis
Journal:  Int J Mol Sci       Date:  2015-05-22       Impact factor: 5.923

Review 7.  Antiangiogenic Effect of Flavonoids and Chalcones: An Update.

Authors:  Ladislav Mirossay; Lenka Varinská; Ján Mojžiš
Journal:  Int J Mol Sci       Date:  2017-12-22       Impact factor: 5.923

Review 8.  Dietary Isoflavones and Breast Cancer Risk.

Authors:  Samira Ziaei; Reginald Halaby
Journal:  Medicines (Basel)       Date:  2017-04-07

9.  A potential daidzein derivative enhances cytotoxicity of epirubicin on human colon adenocarcinoma Caco-2 cells.

Authors:  Yu-Li Lo
Journal:  Int J Mol Sci       Date:  2012-12-21       Impact factor: 5.923

10.  (±)Equol inhibits invasion in prostate cancer DU145 cells possibly via down-regulation of matrix metalloproteinase-9, matrix metalloproteinase-2 and urokinase-type plasminogen activator by antioxidant activity.

Authors:  Wei Zheng; Yumei Zhang; Defu Ma; Yuhui Shi; Changqiu Liu; Peiyu Wang
Journal:  J Clin Biochem Nutr       Date:  2012-03-30       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.